Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock (SEPSIS) Trial
2016-000707-81Phase 2Terminated
- Sponsor
- Capitol Region Blood Bank
- Start
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of fresh-frozen plasma in septic shock (2 arms), sponsored by Capitol Region Blood Bank. Primary endpoints: Efficacy of Octaplas compared to crystalloids and Safety of Octaplas compared to crystalloids. Started Feb 2016; status: terminated.
02
Drugs
fresh-frozen plasma
03
Conditions
septic shock
Beyond the preview
Go deeper on 2016-000707-81.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000707-81.